Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 30.09.2018
ORTIN LABORATORIES LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve Un-audited financial results for the quarter ended 30.09.2018 and any other business with the permission of the Chair. Compliance Certificate (RTA & Compliance Officer)
Compliance certificate (RTA & Compliance Officer) PCS Certificate For Transfer/Transmission/Transposition
PCS Certificate for Transfer/Transmission/Transposition Shareholding for the Period Ended September 30, 2018
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MURALI KRISHNA MURTHY SANKA Designation :- Director Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s report for the AGM held on 29.09.2018 Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Ortin Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Fixes Book Closure for AGM (e-voting)
Ortin Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2018 to September 29, 2018 (both days inclusive) for the purpose of 31st Annual General Meeting (AGM) of the Company to be held on September 29, 2018.